Research Article
Clinical trial of mebendazole, a broad-spectrum anthelminthic.
Br Med J 1975; 2 doi: https://doi.org/10.1136/bmj.2.5966.309 (Published 10 May 1975) Cite this as: Br Med J 1975;2:309
- J G Hutchison,
- N M Johnston,
- M V Plevey,
- I Thangkhiew,
- C Aidney
Abstract
Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.